Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Cosmic Light LLC, 12034-12035 [2021-04180]
Download as PDF
<![CDATA[
12034
Federal Register / Vol. 86, No. 38 / Monday, March 1, 2021 / Notices
Controlled substance
Drug code
AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ..................................................................
Acetylmethadol ................................................................................................................................................................
Alphamethadol .................................................................................................................................................................
Ketobemidone ..................................................................................................................................................................
Noracymethadol ...............................................................................................................................................................
Para-Fluorofentanyl .........................................................................................................................................................
3-Methylfentanyl ..............................................................................................................................................................
Alpha-methylfentanyl .......................................................................................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ...............................................................................
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide .........................................................................................
3-Methylthiofentanyl .........................................................................................................................................................
Cyclopropyl Fentanyl .......................................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11&h) ...................................................................................
Amphetamine ...................................................................................................................................................................
Methamphetamine ...........................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Amobarbital ......................................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
Secobarbital .....................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
Cocaine ............................................................................................................................................................................
Codeine ...........................................................................................................................................................................
Dihydrocodeine ................................................................................................................................................................
Oxycodone .......................................................................................................................................................................
Hydromorphone ...............................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Meperidine intermediate-B ..............................................................................................................................................
Methadone .......................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..............................................................................................................
Morphine ..........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Levo-alphacetylmethadol .................................................................................................................................................
Oxymorphone ..................................................................................................................................................................
Carfentanil .......................................................................................................................................................................
Tapentadol .......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
The company plans to import the
listed controlled substances for
feasibility studies for new products and
cross reactivity studies for existing
products. The products will serve as
raw materials for In Vitro Diagnostic
quantitative assay. No other activity for
these drug codes is authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of the Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–04147 Filed 2–26–21; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
18:48 Feb 26, 2021
Jkt 253001
9551
9601
9605
9628
9633
9812
9813
9814
9821
9825
9833
9845
9850
1100
1105
1724
2125
2270
2315
7471
9041
9050
9120
9143
9150
9180
9193
9220
9230
9233
9250
9273
9300
9333
9648
9652
9743
9780
9801
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Drug Enforcement Administration
comments on or objections to the
issuance of the proposed registration on
or before April 30, 2021.
[Docket No. DEA–781]
ADDRESSES:
DEPARTMENT OF JUSTICE
Bulk Manufacturer of Controlled
Substances Application: Bulk
Manufacturer of Marihuana: Cosmic
Light LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
The Drug Enforcement
Administration (DEA) is providing
notice of an application it has received
from an entity applying to be registered
to manufacture in bulk basic class(es) of
controlled substances listed in schedule
I. DEA intends to evaluate this and other
pending applications according to its
regulations governing the program of
growing marihuana for scientific and
medical research under DEA
registration.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefor, may file written
SUMMARY:
PO 00000
Frm 00116
Fmt 4703
Sfmt 4703
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. To ensure proper handling of
comments, please reference Docket No–
DEA–XXX in all correspondence,
including attachments.
The
Controlled Substances Act (CSA)
prohibits the cultivation and
distribution of marihuana except by
persons who are registered under the
CSA to do so for lawful purposes. In
accordance with the purposes specified
in 21 CFR 1301.33(a), DEA is providing
notice that the entity identified below
has applied for registration as a bulk
manufacturer of schedule I controlled
substances. In response, registered bulk
manufacturers of the affected basic
class(es), and applicants therefor, may
file written comments on or objections
of the requested registration, as
SUPPLEMENTARY INFORMATION:
E:\FR\FM\01MRN1.SGM
01MRN1
Federal Register / Vol. 86, No. 38 / Monday, March 1, 2021 / Notices
provided in this notice. This notice does
not constitute any evaluation or
determination of the merits of the
application submitted.
The applicant plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for product development and
distribution to DEA registered
researchers. If the application for
registration is granted, the registrant
would not be authorized to conduct
other activity under this registration
aside from those coincident activities
specifically authorized by DEA
regulations. DEA will evaluate the
application for registration as a bulk
manufacturer for compliance with all
applicable laws, treaties, and
regulations and to ensure adequate
safeguards against diversion are in
place.
As this applicant has applied to
become registered as a bulk
manufacturer of marihuana, the
application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA will
conduct this evaluation in the manner
described in the rule published at 85 FR
82333 on December 18, 2020, and
reflected in DEA regulations at 21 CFR
part 1318.
In accordance with 21 CFR
1301.33(a), DEA is providing notice that
on January 14, 2021, Cosmic Light LLC,
5565 Ara Pahoe Avenue, Suite G,
Boulder, Colorado 80303–1334, applied
to be registered as a bulk manufacturer
of the following basic class(es) of
controlled substances:
Controlled substance
Marihuana Extract ...................
Marihuana ...............................
Drug
code
7350
7360
Schedule
I
I
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–04180 Filed 2–26–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Federal Bureau of Investigation
[OMB Number 1110–0074]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Extension,
Without Change, of a Previously
Approved Collection; FBI Hazardous
Devices School Application
Hazardous Device School,
Critical Incident Response Group,
Federal Bureau of Investigation,
Department of Justice.
ACTION: 60-day notice.
AGENCY:
VerDate Sep<11>2014
18:48 Feb 26, 2021
Jkt 253001
The Department of Justice
(DOJ), Federal Bureau of Investigation
(FBI), Critical Incident Response Group
(CIRG), Hazardous Devices School
(HDS) will be submitting the following
information collection request to the
Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The proposed
information collection is published to
obtain comments from the public and
affected agencies.
DATES: Comments are encouraged and
will be accepted for 60 days until April
30, 2021.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Mark H. Wall, Supervisory Management
and Program Analyst, FBI, Hazardous
Devices School, at telephone number
(540) 424–4575, 7010 Redstone Road,
Huntsville, AL 35898.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Bureau of Justice
Statistics, including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
SUMMARY:
Overview of This Information Collection
1. Type of Information Collection:
Extension, without change, of a
previously approved collection.
2. The Title of the Form/Collection:
Federal Bureau of Investigation
PO 00000
Frm 00117
Fmt 4703
Sfmt 4703
12035
hazardous Devices School Course
Application.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
The form number FD–731. Federal
Bureau of Investigation (FBI).
4. Affected public who will be asked
or required to respond, as well as a brief
abstract: This form is utilized by the
FBI, Hazardous Devices School to
information needed during a review
process of the identification and
qualification of prospective students,
and to initiate a review of security
clearance status prior to being granted
access to law enforcement sensitive and
classified facilities and information.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that 1,000
respondents will complete each form
within approximately 45 minutes.
6. An estimate of the total public
burden (in hours) associated with the
collection: There are an estimated 750
total annual burden hours associated
with this collection.
If additional information is required,
contact: Melody Braswell, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, 3E.405A,
Washington, DC 20530.
Dated: February 23, 2021.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2021–04189 Filed 2–26–21; 8:45 am]
BILLING CODE 4410–02–P
DEPARTMENT OF JUSTICE
Notice of Proposed Settlement
Agreement Under the Oil Pollution Act
and Clean Water Act
Notice is hereby given that the United
States of America, on behalf of the
Department of the Interior (‘‘DOI’’)
acting through the U.S. Fish and
Wildlife Service and the State of Iowa,
acting through the Iowa Department of
Natural Resources (‘‘IDNR’’) (DOI and
IDNR collectively, the ‘‘Trustees’’), are
providing an opportunity for public
comment on a proposed Settlement
Agreement (‘‘Settlement Agreement’’)
among the Trustees and Canadian
Pacific Railway (‘‘CP’’).
The settlement resolves the civil
claims of the Trustees against CP arising
under their natural resource trustee
authority under the Oil Pollution Act of
1990, 33 U.S.C. 2702 and the Clean
E:\FR\FM\01MRN1.SGM
01MRN1
]]>Agencies
[Federal Register Volume 86, Number 38 (Monday, March 1, 2021)]
[Notices]
[Pages 12034-12035]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-04180]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-781]
Bulk Manufacturer of Controlled Substances Application: Bulk
Manufacturer of Marihuana: Cosmic Light LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA) is providing notice
of an application it has received from an entity applying to be
registered to manufacture in bulk basic class(es) of controlled
substances listed in schedule I. DEA intends to evaluate this and other
pending applications according to its regulations governing the program
of growing marihuana for scientific and medical research under DEA
registration.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefor, may file written comments on or objections to
the issuance of the proposed registration on or before April 30, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. To ensure proper
handling of comments, please reference Docket No-DEA-XXX in all
correspondence, including attachments.
SUPPLEMENTARY INFORMATION: The Controlled Substances Act (CSA)
prohibits the cultivation and distribution of marihuana except by
persons who are registered under the CSA to do so for lawful purposes.
In accordance with the purposes specified in 21 CFR 1301.33(a), DEA is
providing notice that the entity identified below has applied for
registration as a bulk manufacturer of schedule I controlled
substances. In response, registered bulk manufacturers of the affected
basic class(es), and applicants therefor, may file written comments on
or objections of the requested registration, as
[[Page 12035]]
provided in this notice. This notice does not constitute any evaluation
or determination of the merits of the application submitted.
The applicant plans to manufacture bulk active pharmaceutical
ingredients (APIs) for product development and distribution to DEA
registered researchers. If the application for registration is granted,
the registrant would not be authorized to conduct other activity under
this registration aside from those coincident activities specifically
authorized by DEA regulations. DEA will evaluate the application for
registration as a bulk manufacturer for compliance with all applicable
laws, treaties, and regulations and to ensure adequate safeguards
against diversion are in place.
As this applicant has applied to become registered as a bulk
manufacturer of marihuana, the application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA will conduct this evaluation in the
manner described in the rule published at 85 FR 82333 on December 18,
2020, and reflected in DEA regulations at 21 CFR part 1318.
In accordance with 21 CFR 1301.33(a), DEA is providing notice that
on January 14, 2021, Cosmic Light LLC, 5565 Ara Pahoe Avenue, Suite G,
Boulder, Colorado 80303-1334, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana Extract...................... 7350 I
Marihuana.............................. 7360 I
------------------------------------------------------------------------
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-04180 Filed 2-26-21; 8:45 am]
BILLING CODE 4410-09-P
